TOI-1416: A system with a super-Earth planet with a 1.07 d period von Deeg, H.J., Georgieva, I.Y., Nowak, G., Persson, C.M., Cale, B.L., Murgas, F., Pallé, E., Godoy-Rivera, D., Dai, F., Ciardi, D.R., Murphy, J.M.A., Beck, P.G., Burke, C.J., Cabrera, J., Carleo, I., Cochran, W.D., Collins, K.A., Csizmadia, S., El Mufti, M., Fridlund, C.W.M., Fukui, A., Gandolfi, D., García, R.A., Guenther, E.W., Guerra, P., Grziwa, S., Isaacson, H., Isogai, K., Jenkins, J.M., Kábath, P., Korth, J., Lam, K.W.F., Latham, D.W., Luque, R., Lund, M.B., Livingston, J.H., Mathis, S., Mathur, S., Narita, N., Orell-Miquel, J., Osborne, H.L.M., Parviainen, H., Plavchan, P.P., Redfield, S., Rodriguez, D.R., Schwarz, R.P., Seager, S., Smith, A.M.S., Van Eylen, V., Van Zandt, J., Winn, J.N., Ziegler, C.

Volltext bestellen

Cytokinin response factors regulate PIN-FORMED auxin transporters von Šimášková, Mária, O’Brien, José Antonio, Khan, Mamoona, Van Noorden, Giel, Ötvös, Krisztina, Vieten, Anne, De Clercq, Inge, Van Haperen, Johanna Maria Adriana, Cuesta, Candela, Hoyerová, Klára, Vanneste, Steffen, Marhavý, Peter, Wabnik, Krzysztof, Van Breusegem, Frank, Nowack, Moritz, Murphy, Angus, Friml, Jiří, Weijers, Dolf, Beeckman, Tom, Benková, Eva

Volltext

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAA α2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers von de Haas, S.L., de Visser, S.J., van der Post, J.P., de Smet, M., Schoemaker, R.C., Rijnbeek, B., Cohen, A.F., Vega, J.M., Agrawal, N.G.B., Goel, T.V., Simpson, R.C., Pearson, L.K., Li, S., Hesney, M., Murphy, M.G., van Gerven, J.M.A.

Volltext

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA α2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers von de Haas, S.L., de Visser, S.J., van der Post, J.P., Schoemaker, R.C., van Dyck, K., Murphy, M.G., de Smet, M., Vessey, L.K., Ramakrishnan, R., Xue, L., Cohen, A.F., van Gerven, J.M.A.

Volltext

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA A α 2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers von de Haas, S.L., de Visser, S.J., van der Post, J.P., Schoemaker, R.C., van Dyck, K., Murphy, M.G., de Smet, M., Vessey, L.K., Ramakrishnan, R., Xue, L., Cohen, A.F., van Gerven, J.M.A.

Volltext

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA a2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers von de Haas, S.L, de Visser, S.J, van der Post, J.P, Schoemaker, R.C, van Dyck, K, Murphy, M.G, de Smet, M, Vessey, L.K, Ramakrishnan, R, Xue, L, Cohen, A.F, van Gerven, J.M.A

Volltext

Pharmacodynamic and pharmacokinetic effects of TPA023, a GAB[A.sub.A] [α.sub.2,3] subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers von de Haas, S.L, de Visser, S.J, van der Post, J.P, de Smet, M, Schoemaker, R.C, Rijnbeek, B, Cohen, A.F, Vega, J.M, Agrawal, N.G.B, Goel, T.V, Simpson, R.C, Pearson, L.K, Li, S, Hesney, M, Murphy, M.G, van Gerven, J.M.A

Volltext

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA A α 2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers von de Haas, S.L., de Visser, S.J., van der Post, J.P., de Smet, M., Schoemaker, R.C., Rijnbeek, B., Cohen, A.F., Vega, J.M., Agrawal, N.G.B., Goel, T.V., Simpson, R.C., Pearson, L.K., Li, S., Hesney, M., Murphy, M.G., van Gerven, J.M.A.

Volltext